30.06.2025
Alithea Bio at #BayOConnect2025: Let’s Shape the Future of Immunotherapy
We’re excited to announce that Alithea Bio will be attending #BayOConnect2025 in Munich on 1–2 July 2025.
We’re excited to announce that Alithea Bio will be attending BayOConnect in Munich on 1–2 July 2025.
Our Chief Scientific Officer, Dr. Tim Fugmann, will be taking the stage on 2 July 2025, between 11:30 AM and 12:30 PM, to share insights into our cutting-edge work in immunotherapy.
📍 Schedule a meeting with us to discuss
-
Navigating peptide presentation with HLA-Compass
-
Discovering and validating target (neo)epitopes
-
Predicting off-target toxicity
-
Exploring our HLA-typed biorepository
If you’re attending the conference, we’d love to connect and explore how Alithea Bio can support your goals in immunotherapy, cancer research, and HLA-peptidomics.
Let’s shape the future of precision medicine together.
Read more
Webinar Recap: How HLA-Compass is Transforming Immunopeptidomics for Safer, Faster Immunotherapy
Read
Alithea Bio zu Gast bei der Meisterklasse von Gründermotor
Die Investment Readiness Meisterklasse ist ein 5-wöchiges Accelerator-Programm des Gründermotors. Das Ziel ist Startups, die in den nächsten 3-6 Monaten...
Read